Cancer-specific data includes cancer stages (I-IV), presence of metastasis, expression of estrogen receptors (ER), progesterone receptors (PR), HER2 receptors, and triple-negative breast cancer. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.